SUBSCRIBE
SUBSCRIBE
News   Deals

Hikma Pharmaceuticals To Buy Generic Cancer Drug Business Ribosepharm For $45 Million

January 24, 2007 | 
1 min read
LONDON (AFX) - Generic drug maker Hikma Pharmaceuticals PLC has agreed to buy Germany's Ribosepharm, which specialises in selling and marketing cancer treatments, for 45 mln usd.

>>> Discuss This Story

Mergers & acquisitions Europe
MORE ON THIS TOPIC
Active construction site with cranes, workers, builders and skyscrapers under development. Process of building. Vector illustration. Line art style. Isometric view of a monolithic frame building.
Manufacturing
Niowave, fresh from Novartis deal, starts building $75M radioisotope plant
May 26, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Covid-19 vaccine race concept. Syringes flying like a missile, rocket, or jet plane. Blue background
Mergers & Acquisitions
Lilly lands vaccine trifecta with 3 new biotech buys valued at up to $3.8B
May 26, 2026
 · 
5 min read
 · 
Annalee Armstrong
Investment mistakes, taxes, expenses, and unknown costs drain money, concept of Businessman carries a money bag with a big hole, banknotes falling out
Funding
Recordati fields $12.4B go-private offer
May 22, 2026
 · 
2 min read
 · 
Tristan Manalac
High Quality background with Two Flags of South Korea and USA
Manufacturing
Gilead inks $140M API supply deal, tightening ties to Korean manufacturer
May 22, 2026
 · 
1 min read
 · 
Nick Paul Taylor